Viewing Study NCT01139359


Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-01-01 @ 6:28 PM
Study NCT ID: NCT01139359
Status: WITHDRAWN
Last Update Posted: 2012-07-19
First Post: 2010-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma
Sponsor: Alaunos Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module